Zobrazeno 1 - 10
of 89
pro vyhledávání: '"Kusuya, Nishioka"'
Autor:
Motoko Sakamoto, Kusuya Nishioka
To break the vicious circle between malnutrition and severe infection which has been linked to the great magnitude of infant deaths worldwide, we have been searching by means of clinical and experimental studies for measures which provide for rapid e
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::42611c9a2c9b4dac714abb9c3b68ac68
https://doi.org/10.1159/000419462
https://doi.org/10.1159/000419462
Autor:
Kusuya Nishioka, Akira Yoshikawa, Kimihiro Kanemitsu, Masako Itabashi, Yuhko Gotanda, Kiyoshi Minegishi
Publikováno v:
Vox Sanguinis. 88:77-86
Background and Objectives The Japanese Red Cross (JRC) carries out nucleic acid amplification testing (NAT) for hepatitis B virus (HBV), hepatitis C virus (HCV) and human immunodeficiency virus-1 (HIV-1) by using a multiplex (MPX) reagent. Screening
Autor:
Hiroyuki Emura, Hiroyuki Murokawa, Kiyoshi Minegishi, Akira Yoshikawa, Retsuji Yamanaka, Kusuya Nishioka, Hideko Mine, Tsugikazu Tomono, Masaki Miyamoto
Publikováno v:
Journal of Virological Methods. 112:145-151
Nationwide nucleic acid amplification testing (NAT) for hepatitis B virus (HBV), hepatitis C virus (HCV) and human immunodeficiency virus type 1 (HIV-1) of blood donated voluntarily after serological screening was implemented on July 1st 1999 for tra
Autor:
Tsugikazu Tomono, Shigeki Yokoyama, Toru Hirose, Masaki Miyamoto, H Ohnuma, Takeshi Tanaka, Kusuya Nishioka, Hideko Mine, Kiyoshi Minegishi, Akira Yoshikawa, Yoshio Takeda, Retsuji Yamanaka, Yasushi Doi, Takashi Murozuka, Seiji Nakahira, Hisao Yugi Lizuka, Hiroyuki Murokawa, Shuhei Satoh
Publikováno v:
Microbiology and Immunology. 45:667-672
The first nationwide nucleic acid amplification testing (NAT) for hepatitis B virus (HBV), hepatitis C virus (HCV), and human immunodeficiency virus type 1 (HIV-1) of voluntarily donated blood after serological pre-screening and before release of cel
Publikováno v:
Microbiology and Immunology. 44:799-804
Glycyrrhizin, an aqueous extract of licorice root, has anti-inflammatory activity and has been used for the treatment of chronic viral hepatitis. In the present study we describe the mechanism by which glycyrrhizin inhibits complement. Glycyrrhizin i
Autor:
Kenji Okuda, Ken-ichi Kusakabe, Ichiro Aoki, Susumu Kawamoto, Eri Hagiwara, Hidenori Katoh, Dennis M. Klinman, Katsuji Okuda, Kusuya Nishioka, Kaharu Sumino, Ke-Qin Xin, Yohei Miyagi
Publikováno v:
The Journal of Immunology. 164:3102-3111
The mechanism of immune activation induced by a plasmid-encoding GM-CSF (pGM-CSF), administered in combination with a DNA vaccine encoding the envelope of HIV, was studied. Injecting pGM-CSF i.m. into mice 3 days before DNA vaccination primarily indu
Autor:
Stanley M. Lemon, Thomas J. Layden, Leonard Seeff, Hiroshi Suzuki, Kusuya Nishioka, Shunji Mishiro, Leslye Johnson
Publikováno v:
Hepatology. 31:800-806
A series of international symposia on viral hepatitis and liver disease has been held triannially, and called the'Olympics'of this research field. Our book presents the results of the eighth of these'Olympiads'which for the first time, was held in As
Autor:
Leslye Johnson, Michael M. C. Lai, Francis V. Chisari, Stanley M. Lemon, Kusuya Nishioka, Shunji Mishiro
Publikováno v:
Hepatology. 28:881-887
Autor:
Ding-Shinn Chen, Kusuya Nishioka, Tammy S. Pajeau, Po-ya Chang, Baruch Blumberg, Charles L. Bennett, Juei-Low Sung, Hsu-Mei Hsu, Andrew T. Huang
Publikováno v:
Cancer Causes and Control. 7:305-311
Approximately 15 percent of the Taiwanese population are chronic carriers of hepatitis B virus (HBV), among the highest rates in Asia. In July 1984, the Taiwanese government initiated a nationwide HBV-vaccination program. The program began with educa